NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

QNTM

Quantum BioPharma Ltd

Jul 07 • 10:01AM ET

16.15

Dollar change -0.91
Percentage change -5.33	%

Healthcare • Biotechnology • Canada • NASD

Peers: JNJ PFE MRK BMY LLY GILD REGN AMGN BIIB VRTX

| Held by: PSIL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-14.82	Insider Own	-	Shs Outstand	2.71M	Perf Week	-25.64%
Market Cap	43.77M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	-	Shs Float	2.38M	Perf Month	11.15%
Enterprise Value	37.57M	PEG	-	EPS next Q	-0.17	Inst Own	2.58%	Short Float	5.80%	Perf Quarter	105.47%
Income	-20.88M	P/S	-	EPS this Y	73.09%	Inst Trans	0.61%	Short Ratio	0.56	Perf Half Y	338.86%
Sales	0.00M	P/B	7.64	EPS next Y	67.42%	ROA	-137.74%	Short Interest	0.14M	Perf YTD	338.86%
Book/sh	2.11	P/C	6.97	EPS next 5Y	-	ROE	-235.05%	52W High	38.25 -57.78%	Perf Year	69.02%
Cash/sh	2.32	P/FCF	-	EPS past 3/5Y	42.48% 48.95%	ROIC	-364.17%	52W Low	2.70 498.15%	Perf 3Y	-68.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	13.41% 18.25%	Perf 5Y	-93.71%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	11.88%	Oper. Margin	-	ATR (14)	3.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.95	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	45.02	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.96	EPS Q/Q	-11.07%	SMA20	-23.26%	Beta	0.69	Target Price	35.50
Payout	-	Debt/Eq	0.22	Sales Q/Q	-	SMA50	11.09%	Rel Volume	2.41	Prev Close	17.06
Employees	7	LT Debt/Eq	0.00	Earnings	May 14 BMO	SMA200	112.14%	Avg Volume	245.58K	Price	16.15
IPO	Jun 08, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	-443.08% 0.00%	Trades		Volume	74,315	Change	-5.33%

Jun-27-25 04:30PM	Quantum BioPharma Announces Private Placement (GlobeNewswire) -6.77%
04:30PM	Quantum BioPharma Announces Private Placement of 12 Class A Multiple Voting Shares at a Price of $50 Per Share (GlobeNewswire)
Jun-26-25 07:30AM	Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering (GlobeNewswire) -13.34%
Jun-18-25 09:19AM	Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress (Newsfile) +17.29%
Jun-17-25 08:00AM	Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital (GlobeNewswire) +19.95%
07:00AM	Loading…
Jun-13-25 07:00AM	Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds (GlobeNewswire)
Jun-10-25 08:00AM	Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000 (GlobeNewswire)
Jun-03-25 07:50AM	Quantum BioPharma Clarifies It Has Not Changed Its Name (GlobeNewswire)
May-30-25 07:00AM	Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari (GlobeNewswire) +7.00%
May-29-25 07:30AM	Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc. (GlobeNewswire) +7.16%
May-28-25 08:00AM	Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome (GlobeNewswire)
May-21-25 08:00AM	Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets (GlobeNewswire) +7.99%
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE) -7.10%
07:30AM	Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis (GlobeNewswire)
May-19-25 07:30AM	Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000 (GlobeNewswire) +19.61%
07:30AM	Loading…
May-16-25 07:30AM	Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference (GlobeNewswire) +12.02%
May-12-25 08:00AM	Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis (GlobeNewswire)
May-05-25 07:08AM	Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (GlobeNewswire) +10.84%
Apr-24-25 07:00AM	Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time (GlobeNewswire)
Apr-22-25 07:00AM	Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor (GlobeNewswire)
Apr-18-25 04:00PM	Quantum BioPharma Corporate Update (Newsfile)
Apr-14-25 07:30AM	Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario (GlobeNewswire)
Apr-10-25 07:30AM	Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd (GlobeNewswire) -6.82%
Apr-03-25 07:00AM	Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico (GlobeNewswire)
Apr-01-25 02:00AM	Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis (GlobeNewswire)
Mar-31-25 07:00AM	Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms (GlobeNewswire) -9.93%
Mar-30-25 07:00PM	Quantum BioPharma Provides Corporate Update (Newsfile)
Mar-28-25 09:15AM	Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern (ACCESSWIRE)
Mar-27-25 07:00AM	Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors (GlobeNewswire) +20.58%
Mar-26-25 07:00AM	Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd Alcohol Detox Product Lineup for Retail Sales (GlobeNewswire) +18.60%
08:09AM	Loading…
Mar-20-25 08:09AM	Quantum Group purchases additional $1.5M worth of Bitcoin (SeekingAlpha)
07:30AM	Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies (GlobeNewswire)
Mar-17-25 11:33AM	Quantum BioPharma Unaware of Any Material Change (Newsfile) +46.83%
Mar-07-25 03:00PM	Quantum BioPharma Provides Corporate Update (Newsfile)
Feb-28-25 11:30AM	Psychedelic: GH Research, Compass Pathways report earnings results (TipRanks) -7.89%
Feb-26-25 07:30AM	Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302 (GlobeNewswire)
Feb-18-25 07:30AM	Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies (GlobeNewswire) -5.21%
Feb-11-25 07:30AM	Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program (GlobeNewswire)
Feb-10-25 07:30AM	Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs (GlobeNewswire) +8.22%
Feb-06-25 07:30AM	Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd Clinical Study (GlobeNewswire) +69.00%
Feb-04-25 08:00AM	Quantum to Release Fiscal Third Quarter 2025 Financial Results on Wednesday, February 12, 2025 (Business Wire) +111.01%
07:03AM	Quantum Biopharma Announces the Success of unbuzzd Clinical Trial (GlobeNewswire)
Jan-17-25 07:30AM	Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates (ACCESSWIRE)
Jan-14-25 08:30AM	Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM (ACCESSWIRE)
Jan-07-25 08:30AM	Quantum Biopharma Ltd. Approved to Dual List on Upstream (ACCESSWIRE)
Dec-20-24 07:30PM	Quantum Biopharma Announces Closing of Second Tranche (ACCESSWIRE) -13.29% +7.00%
09:15AM	Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency (ACCESSWIRE)
Dec-13-24 07:00PM	Quantum Biopharma Announces Closing of First Tranche (ACCESSWIRE)
Dec-10-24 07:30AM	Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) (ACCESSWIRE)
Dec-05-24 07:30AM	Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million (ACCESSWIRE)
Nov-25-24 07:00AM	Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation (ACCESSWIRE)
Oct-29-24 07:30AM	Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia (ACCESSWIRE)
Oct-28-24 11:10AM	Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma (PR Newswire)
Oct-23-24 09:30AM	Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma (PR Newswire) +15.45%
Oct-22-24 07:00AM	Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (ACCESSWIRE) -17.33%
Oct-21-24 11:55AM	Quantum BioPharma Ltd. Alleges Market Manipulation, Files Lawsuit, unbuzzed Continues To Gain Traction (News Direct) -9.80%
07:00AM	Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (ACCESSWIRE)
05:30AM	Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (Newsfile)
Oct-15-24 06:00AM	Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd (News Direct)
Oct-07-24 08:40AM	Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America (Newsfile) -8.26%
Sep-27-24 08:06PM	Quantum Biopharma Provides Corporate Update (ACCESSWIRE)
Sep-25-24 09:20AM	Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US (ACCESSWIRE)
Sep-13-24 04:00PM	Quantum BioPharma Closes Private Placement Offering (Newsfile)
Sep-09-24 07:30AM	Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis (ACCESSWIRE)
Sep-06-24 07:30PM	Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements (ACCESSWIRE)
Aug-30-24 10:30AM	Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 (ACCESSWIRE) -8.30%
07:30AM	Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can 'own NOW and what's NEXT' (ACCESSWIRE)
Aug-23-24 07:30PM	Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update (ACCESSWIRE)
Aug-15-24 06:00AM	FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol 'QNTM' (Newsfile) -26.93%
Aug-12-24 07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -35.05%
Aug-09-24 04:00PM	FSD Pharma Announces Share Consolidation and Name Change (Newsfile) +120.75%
10:51AM	FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock? (InvestorPlace)
07:30AM	FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team (ACCESSWIRE)
Jul-25-24 09:20AM	24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma (Newsfile)
Jul-23-24 03:34PM	FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders (Newsfile) +10.21%
10:29AM	24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma (Newsfile)
Jul-04-24 08:00AM	FSD Pharma Files Amended and Restated Material Change Report (Newsfile)
Jun-28-24 05:00PM	FSD Pharma provides Corporate Update (ACCESSWIRE) -15.44%
07:30AM	FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd. (ACCESSWIRE)
Jun-27-24 07:30AM	FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia (ACCESSWIRE) -5.03%
Jun-13-24 07:30AM	FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications (ACCESSWIRE) -9.92%
Jun-04-24 07:30AM	FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication (ACCESSWIRE)
Jun-02-24 03:42PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector week of 6/2/24 (Market Exclusive)
May-31-24 07:30AM	FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest (ACCESSWIRE)
May-28-24 08:00AM	FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication (ACCESSWIRE)
May-24-24 05:15PM	FSD Pharma Provides Corporate Update (ACCESSWIRE)
May-20-24 10:53AM	HUGE Stock Earnings: FSD Pharma Reported Results for Q1 2024 (InvestorPlace) +9.72%
May-16-24 08:00AM	FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM) (ACCESSWIRE)
May-07-24 08:30AM	FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia (ACCESSWIRE)
Apr-30-24 08:33AM	FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication (ACCESSWIRE) -6.96%
Apr-25-24 07:47AM	FSD Pharma Provides Update from Celly Nu's Partnership with Six+One for unbuzzd(TM) (ACCESSWIRE)
Apr-22-24 08:00AM	FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) (ACCESSWIRE)
Apr-17-24 08:00AM	FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products (ACCESSWIRE) -7.80%
Apr-15-24 08:00AM	FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption (ACCESSWIRE) -12.40%
Apr-07-24 10:55PM	FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (Newsfile)
Apr-01-24 10:00PM	FSD Pharma Announces Filing of Year-End 2023 Results (ACCESSWIRE)
Mar-27-24 08:00AM	FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults (ACCESSWIRE)
Mar-11-24 08:00AM	FSD Pharma Submits a Phase-1b Clinical Trial Application for Ethics Committee for its Proprietary Beverage unbuzzd(TM) (ACCESSWIRE)
Mar-05-24 08:00AM	FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum (ACCESSWIRE)
Feb-28-24 08:00AM	FSD Pharma Announces Debt Settlement (ACCESSWIRE)

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QNTM

Quantum BioPharma Ltd

Upgrade your FINVIZ experience